Medtronic finalizes Covidien buy for $50B

Candace Stuart | January 26, 2015 | Cardiovascular Business | Patient Care

Medtronic completed its acquisition of Covidien in lockstep with the Irish High Court’s sanctioning of the deal. The two companies now exist under the name Medtronic plc, with executive offices in Ireland.

Medtronic announced in June 2014 that it planned to buy Covidien for $43 billion. The final cash-and-stock transaction totaled almost $50 billion. The deal allowed the two companies to combine a variety of cardiovascular product lines and services and move headquarters to Ireland, which has a much lower corporate tax rate than the U.S.

Covidien and Medtronic shares ceased trading on the New York Stock Exchange at the close of business Jan. 26. Trading of Medtronic plc shares under the symbol "MDT" should begin Jan. 27.

Medtronic plc has more than 85,000 employees working in 160 countries. While the principal executive offices are in Ireland, its operational headquarters remained in Minneapolis.

Candace Stuart, Contributor

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Medtronic finalizes Covidien buy for $50B

Related Content

Around the web